Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating severe eye allergy

P Verin1

  • 1Université Victor Segalen, Bordeaux, France.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|February 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2003
Same author

Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.

European journal of ophthalmology·2001
Same author

Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.

American journal of ophthalmology·2001
Same author

Two chromene derivatives from Calyptranthes tricona.

Phytochemistry·2000
Same author

[Hereditary retinal macrovessel. Report of 2 cases].

Journal francais d'ophtalmologie·2000
Same author

[Vitreous hemorrhage and pre-retinal hemorrhage "without obvious point of origin" in diabetic patients. Apropos of 5 cases].

Journal francais d'ophtalmologie·1999
Same journal

GWAS of Second-Generation Antihistamine Use: Locus Specificity and Highlighted Signalling Pathways.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Basophil Activation Test Provides Additional Diagnostic Value Beyond Ara h 2-Specific IgE Testing in Peanut Allergic Adults.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Characterisation of Allergen Profiles in Commercial Egg Products to Inform Oral Immunotherapy Strategies in Egg Allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Allergic Diseases and Risk of Incident Autoimmune Diseases: Phenotype-Specific Patterns and Multimorbidity Effects in a Nationwide Cohort.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Determinants of Total and Inhaled Allergen-Specific Immunoglobulin E in the Middle-Aged and Elderly Population.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Rhinitis-Related Healthcare Utilization in Colombian Adults, 2015-2024.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
See all related articles

Nedocromil sodium eyedrops offer effective relief for allergic eye conditions like seasonal allergic conjunctivitis (SAC). This mast-cell stabilizer provides potent symptom control with convenient dosing, showing significant benefits over placebo and comparable or superior efficacy to other treatments.

Area of Science:

  • Ophthalmology
  • Allergology
  • Pharmacology

Background:

  • Allergic eye conditions, such as seasonal allergic conjunctivitis (SAC), are prevalent and cause significant discomfort.
  • Current treatments include topical H1-antagonists and sodium cromoglycate, with varying efficacy and dosing frequencies.

Purpose of the Study:

  • To evaluate the efficacy and safety of nedocromil sodium in treating allergic eye conditions.
  • To compare nedocromil sodium with placebo, sodium cromoglycate, and levocabastine in patients with SAC, perennial allergic conjunctivitis (PAC), and vernal keratoconjunctivitis (VKC).

Main Methods:

  • Meta-analysis of placebo-controlled studies for SAC treatment.
  • Comparative efficacy studies of nedocromil sodium versus sodium cromoglycate and levocabastine.

Related Experiment Videos

  • Clinical and patient-reported outcomes in PAC and VKC treatment.

    • Main Results:

    • Nedocromil sodium demonstrated significant symptom relief in 80% of SAC patients.
    • It showed comparable efficacy to sodium cromoglycate but superior efficacy to placebo during high pollen challenge.
    • Nedocromil sodium exhibited equivalent efficacy to levocabastine with a potentially faster onset of action and superior symptom control in PAC and VKC compared to sodium cromoglycate.

    Conclusions:

    • Nedocromil sodium is a potent and well-tolerated mast-cell stabilizer for allergic eye conditions.
    • Its convenient twice-daily dosing and significant efficacy make it a valuable therapeutic option, particularly for SAC, PAC, and VKC.
    • Nedocromil sodium offers advantages over existing treatments, including reduced need for steroid rescue medication in VKC.